Showing results (151-160 of 423) with videos related to

Sort By:
Pageof 43
Journal of the Society for Gynecologic Investigation|February 13, 2002
High levels of human chromogranin A in umbilical cord plasma and amniotic fluid at parturitionPasquale Florio, Alessandra Mezzesimi, Vera Turchetti, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|July 24, 2007
Activin A and follistatin in menstrual blood: low concentrations in women with dysfunctional uterine bleedingFernando M Reis, Lívia L Nascimento, Anastasia Tsigkou, et al.
Reproductive Biomedicine Online|June 25, 2020
Comorbidities, risk factors and maternal/perinatal outcomes in oocyte donation pregnanciesFrancesca Rizzello, Maria Elisabetta Coccia, Cinzia Fatini, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|July 24, 2015
Mood disorders and quality of life in polycystic ovary syndromeAgnieszka Podfigurna-Stopa, Stefano Luisi, Cristina Regini, et al.
Treatments in Endocrinology|October 30, 2004
Menopause, the cardiovascular risk factor homocysteine, and the effects of treatmentVincenzo De Leo, Antonio la Marca, Giuseppe Morgante, et al.
Journal of the Society for Gynecologic Investigation|May 4, 2004
High concentrations of activin A in the peritoneal fluid of women with epithelial ovarian cancerLuigi Cobellis, Fernando M Reis, Stefano Luisi, et al.
Current Pharmaceutical Biotechnology|June 11, 2011
Present and future of recombinant gonadotropins in reproductive medicineVincenzo De Leo, Maria Concetta Musacchio, Alessandra Di Sabatino, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|April 24, 2009
Activin A, activin receptor type II, nodal, and cripto mRNA are expressed by eutopic and ectopic endometrium in women with ovarian endometriosisPaulo B Torres, Pasquale Florio, Letizia Galleri, et al.
Expert Opinion on Pharmacotherapy|September 13, 2016
Pharmacologic treatment of the ovarian endometriomaGiuseppe Benagiano, Sun-Wei Guo, Paola Bianchi, et al.
Pageof 43